Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Molecular bases of human neurocristopathies.

Etchevers HC, Amiel J, Lyonnet S.

Adv Exp Med Biol. 2006;589:213-34. Review. No abstract available.

PMID:
17076285
2.

The neural crest: a versatile organ system.

Zhang D, Ighaniyan S, Stathopoulos L, Rollo B, Landman K, Hutson J, Newgreen D.

Birth Defects Res C Embryo Today. 2014 Sep;102(3):275-98. doi: 10.1002/bdrc.21081. Epub 2014 Sep 16. Review.

PMID:
25227568
3.

Neural crest-specific removal of Zfhx1b in mouse leads to a wide range of neurocristopathies reminiscent of Mowat-Wilson syndrome.

Van de Putte T, Francis A, Nelles L, van Grunsven LA, Huylebroeck D.

Hum Mol Genet. 2007 Jun 15;16(12):1423-36. Epub 2007 May 3.

PMID:
17478475
4.

Evolution of the neural crest.

Barrallo-Gimeno A, Nieto MA.

Adv Exp Med Biol. 2006;589:235-44. Review.

PMID:
17076286
5.

Neural crest inducing signals.

Basch ML, Bronner-Fraser M.

Adv Exp Med Biol. 2006;589:24-31. Review.

PMID:
17076273
6.

Neurocristopathies and chromosome anomalies.

Friedrich U, Warburg M.

Ann Genet. 1992;35(2):124. No abstract available.

PMID:
1524411
7.

A sensitized mutagenesis screen identifies Gli3 as a modifier of Sox10 neurocristopathy.

Matera I, Watkins-Chow DE, Loftus SK, Hou L, Incao A, Silver DL, Rivas C, Elliott EC, Baxter LL, Pavan WJ.

Hum Mol Genet. 2008 Jul 15;17(14):2118-31. doi: 10.1093/hmg/ddn110. Epub 2008 Apr 7.

8.

The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10.

Agarwal P, Verzi MP, Nguyen T, Hu J, Ehlers ML, McCulley DJ, Xu SM, Dodou E, Anderson JP, Wei ML, Black BL.

Development. 2011 Jun;138(12):2555-65. doi: 10.1242/dev.056804.

9.

Neural crest cells: from developmental biology to clinical interventions.

Noisa P, Raivio T.

Birth Defects Res C Embryo Today. 2014 Sep;102(3):263-74. doi: 10.1002/bdrc.21074. Epub 2014 Sep 16. Review.

PMID:
25226872
10.

CHD7, the gene mutated in CHARGE syndrome, regulates genes involved in neural crest cell guidance.

Schulz Y, Wehner P, Opitz L, Salinas-Riester G, Bongers EM, van Ravenswaaij-Arts CM, Wincent J, Schoumans J, Kohlhase J, Borchers A, Pauli S.

Hum Genet. 2014 Aug;133(8):997-1009. doi: 10.1007/s00439-014-1444-2. Epub 2014 Apr 13.

PMID:
24728844
11.

Bmp2 is required for migration but not for induction of neural crest cells in the mouse.

Correia AC, Costa M, Moraes F, Bom J, Nóvoa A, Mallo M.

Dev Dyn. 2007 Sep;236(9):2493-501.

12.

Probable loose linkage between the ABO locus and Waardenburg syndrome type I.

Arias S, Mota M, Yánez A, Bolivar M.

Humangenetik. 1975;27(2):145-9.

PMID:
1150237
13.

Waardenburg syndrome in South Africa. Part II. Is there founder effect for type I?

de Saxe M, Kromberg JG, Jenkins T.

S Afr Med J. 1984 Aug 25;66(8):291-3.

PMID:
6474292
14.

Mapping dysmorphic syndromes with the aid of the human/mouse homology map.

Erickson RP.

Am J Hum Genet. 1990 Jun;46(6):1013-6. Review. No abstract available.

15.
16.

Waardenburg syndrome in South Africa. Part I. An evaluation of the clinical findings in 11 families.

de Saxe M, Kromberg JG, Jenkins T.

S Afr Med J. 1984 Aug 18;66(7):256-61.

PMID:
6463802
17.

Craniofacial abnormalities induced by ectopic expression of the homeobox gene Hox-1.1 in transgenic mice.

Balling R, Mutter G, Gruss P, Kessel M.

Cell. 1989 Jul 28;58(2):337-47.

PMID:
2568891
18.

Additive dominant effect of a SOX10 mutation underlies a complex phenotype of PCWH.

Ito Y, Inoue N, Inoue YU, Nakamura S, Matsuda Y, Inagaki M, Ohkubo T, Asami J, Terakawa YW, Kohsaka S, Goto Y, Akazawa C, Inoue T, Inoue K.

Neurobiol Dis. 2015 Aug;80:1-14. doi: 10.1016/j.nbd.2015.04.013. Epub 2015 May 7.

PMID:
25959061
19.

Wnt6 controls amniote neural crest induction through the non-canonical signaling pathway.

Schmidt C, McGonnell IM, Allen S, Otto A, Patel K.

Dev Dyn. 2007 Sep;236(9):2502-11.

20.

Zebrafish colourless encodes sox10 and specifies non-ectomesenchymal neural crest fates.

Dutton KA, Pauliny A, Lopes SS, Elworthy S, Carney TJ, Rauch J, Geisler R, Haffter P, Kelsh RN.

Development. 2001 Nov;128(21):4113-25.

Supplemental Content

Support Center